Interestingly, 39 of them were involved in cancer-related molecular pathways (ATXN2, AXIN1, BCL2L11, CAMK2B, CDH15, CDH17, CHUK, COL1A1, COL4A6, COL7A1, CSNK1G1, CTGF, CXCL12, CXCL6, FGF11, FGF5, FZD5, GABRA1, GNAS, GNRH2, HAPLN1, IHH, INSRR, ITGB2, LAMB2, LIFR, MAPK10, MUC1, PIK3R1, PPARGC1A, PSMA7, PTCH1, PTK7, SHC3, TCF4, TGFB2, TNFRSF14, TUBGCP2, and ZEB1). This evidence concerns the gene ATXN2 and cancer.